The page is the record's research on the issuer — no analyst, no rating, no view. # HIKMA PHARMACEUTICALS PLC (LSE Main Market: HIK) — research page As of 2026-11-06 · uk-cm-kg · record version 1 ## Identity and listing The issuer is HIKMA PHARMACEUTICALS PLC, listed on the LSE Main Market under ticker HIK, ISIN GB00B0LCW083, LEI 549300BNS685UXH4JI75. Its security type is Corporate, its segment is STMM, its sector is Pharmaceuticals and Biotechnology [201030], and its jurisdiction is England and Wales (Companies House jurisdiction field). Its listing status is listed, not halted. ## The disclosure read The record holds 139 filings across 86 filing days in the window 2025-11-06 to 2026-11-06. The median gap between filing days is 3 days. The latest filing is dated 2026-11-05 and is of type financial_statement, 1 day before the record date of 2026-11-06. On the LSE Main Market the median cadence gap is 4 days, the median filings count is 29.0 and the median latency is 3 days across 892 issuers. In the sector Pharmaceuticals and Biotechnology [201030] the median cadence gap is 6.0 days, the median filings count is 42 and the median latency is 4.0 days across 51 issuers. ## Auditor The auditor of record is PricewaterhouseCoopers LLP. Its location is not on the record. Auditor changes are not on the record, as this register has no lifecycle type map yet. ## Events and halts Listing, delisting, name change, domicile change and segment move are not on the record, as this register has no lifecycle type map yet. The halt flag is listed, not halted. ## Orderability For the elective professional client category the outcome is signal ACM-200, determinable. For the eligible counterparty category the outcome is signal ACM-200, determinable. The rule version is acm-68000/uk/product-governance-fca-prod-sourcebook/r1, with chapter as of 2026-11-04. ## Coverage The issuer's investor-relations page names 12 research houses: Barclays, Berenberg, BNP Paribas, BofA, Citi, Deutsche Numis, Jefferies, JP Morgan, Panmure Liberum, Peel Hunt, RBC and Stifel. ## Open research No openly published research notes were found on the record. ## Licensed Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded. ## As-of depth The market's vintage is not sealed. No issuer years are sealed. The market earliest sealed date is not on the record. The live record began on 2026-09-11. Years 2021, 2022, 2023, 2024, 2025 and 2026 are sealed in the store but not served as of a date; the as-of door answers not_sealed. ## Sources 11 source pages are named on this page; every value above carries its own source page and read date in the numbers. - https://www.londonstockexchange.com/live-markets/market-data-dashboard/price-explorer (identity.exchange) - https://api.londonstockexchange.com/api/gw/lse/instruments/alldata/HIK (identity.isin) - https://find-and-update.company-information.service.gov.uk/company/05557934 (identity.jurisdiction) - https://mapping.gleif.org/api/v2/isin-lei/latest/download (identity.lei) - https://www.londonstockexchange.com/stock/HIK/hikma-pharmaceuticals-plc/company-page (identity.sector) - https://mcp.uk-cm-kg.ai/events/LSE/HIK (the disclosure lines) - https://marketsecurities.fca.org.uk/officiallist (the halt flag) - https://www.hikma.com/media/f1ppfora/hikma-ar24-financial-statements.pdf (the auditor) - https://mcp.uk-cm-kg.ai/book/aio.json (the orderability chapter) - https://www.hikma.com/investors/company-compiled-consensus/analyst-coverage/ (coverage) - https://mcp.uk-cm-kg.ai/record/LSE/HIK (the record) --- Allooloo Technologies Corp. · https://getresearch.ai/uk/LSE/HIK · public-record only · the same page signed and receipted: get_research at https://mcp.getresearch.ai/mcp